Health
State of Health Brazil results show China's Sinovac vaccine is just 50.4 percent effective against COVID-19
Just Earth News | @justearthnews | 14 Jan 2021, 09:56 pm Print
China COVID-19 Vaccine Brazilian clinical trials have unveiled that a COVID-19 vaccine developed by China's Sinovac has been found to be 50.4% effective, media reports said.
It shows the vaccine is significantly less effective than previous data suggested - barely over the 50% needed for regulatory approval, reports BBC.
The vaccine is one of the two which the Brazilian government has lined up.
Brazil is one of the worst-hit COVID-19 nations in the world.
Sinovac, a Beijing-based biopharmaceutical company, is behind CoronaVac, an inactivated vaccine. It works by using killed viral particles to expose the body's immune system to the virus without risking a serious disease response, reports BBC.
More Health
- Malaria vaccine price slashed! Gavi and UNICEF make life-saving shots cheaper
- Jaw-dropping study reveals humans didn’t invent kissing — Apes started it 21 million years ago!
- Revealed: Ultra-processed foods linked to deadly diseases
- Is Keto ruining your body? Study reveals alarming metabolic risks!
- Short strolls are useless? Experts say this simple walking trick boosts your heart!
-1763561110.jpg "Image of the day: November 19, 2025")
